{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:06:55Z","timestamp":1758478015534},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/cnd.0000000000000057","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T16:34:46Z","timestamp":1416501286000},"page":"106-107","source":"Crossref","is-referenced-by-count":6,"title":["Methotrexate Treatment in Myasthenia Gravis"],"prefix":"10.1097","volume":"16","author":[{"given":"Ozgur Zeliha","family":"Karaahmet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajda","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Dulgeroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan Kadir","family":"Bahceci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytul","family":"Cakci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":". Frequency of autoimmune diseases in myasthenia gravis: a systematic review.","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"R2-11-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-5728(93)90013-O","article-title":"Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis.","volume":"42","author":"Yi","year":"1993","journal-title":"J Neuroimmunol"},{"key":"R3-11-20210126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06804.x","article-title":". Phase II trial of methotrexate in myasthenia gravis.","volume":"1275","author":"Pasnoor","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R4-11-20210126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.","volume":"57","author":"Bruce","year":"2005","journal-title":"Pharmacol Rev"},{"key":"R5-11-20210126","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/eji.201142088","article-title":". Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.","volume":"42","author":"Li","year":"2012","journal-title":"Eur J Immunol"},{"key":"R6-11-20210126","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":". 2010 rheumatoid arthritis classification criteria: an American College of RheumatologyEuropean League Against Rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:24:52Z","timestamp":1621887892000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-201412000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000057","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}